These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 26733255)

  • 21. Evolution and refinement of magnetically guided sentinel lymph node detection in breast cancer: meta-analysis.
    Pantiora E; Tasoulis MK; Valachis A; Eriksson S; Kühn T; Karakatsanis A; Rubio IT
    Br J Surg; 2023 Mar; 110(4):410-419. PubMed ID: 36560842
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of a Magnetic Tracer for Sentinel Lymph Node Detection in Early-Stage Breast Cancer Patients: A Meta-analysis.
    Teshome M; Wei C; Hunt KK; Thompson A; Rodriguez K; Mittendorf EA
    Ann Surg Oncol; 2016 May; 23(5):1508-14. PubMed ID: 26893221
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Response to the article by Thill et al.: "The Central-European SentiMag study: sentinel lymph node biopsy with supermagnetic iron oxide (SPIO) vs. radioisotope". The Breast 2014.
    Barranger E; Ihrai T
    Breast; 2014 Jun; 23(3):297. PubMed ID: 24721742
    [No Abstract]   [Full Text] [Related]  

  • 24. A complete magnetic sentinel lymph node biopsy procedure in oral cancer patients: A pilot study.
    Nieuwenhuis ER; Kolenaar B; van Bemmel AJM; Hof JJ; van Baarlen J; Christenhusz A; Pouw JJ; Ten Haken B; Alic L; de Bree R
    Oral Oncol; 2021 Oct; 121():105464. PubMed ID: 34329868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Response to Barranger E, Ihrai T, response to the article by Thill et al.: "The Central-European SentiMag study: Sentinel lymph node biopsy with supermagnetic iron oxide (SPIO) vs. radioisotope". The Breast 2014, 23(2):175-9.
    Thill M; Kurylcio A; Welter R; van Haasteren V; Grosse B; Berclaz G; Polkowski W; Hauser N
    Breast; 2014 Oct; 23(5):692. PubMed ID: 25067809
    [No Abstract]   [Full Text] [Related]  

  • 26. Preclinical evaluation of a mannose-labeled magnetic tracer for enhanced sentinel lymph node retention in the head and neck.
    Krishnan G; Cousins A; Pham N; Milanova V; Nelson M; Krishnan S; Shetty A; van den Berg N; Rosenthal E; Krishnan S; Wormald PJ; Foreman A; Thierry B
    Nanomedicine; 2022 Jun; 42():102546. PubMed ID: 35278683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sentinel lymph node identification using superparamagnetic iron oxide particles versus radioisotope: The French Sentimag feasibility trial.
    Houpeau JL; Chauvet MP; Guillemin F; Bendavid-Athias C; Charitansky H; Kramar A; Giard S
    J Surg Oncol; 2016 Apr; 113(5):501-7. PubMed ID: 26754343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Magnetic sentinel node and occult lesion localization in breast cancer (MagSNOLL Trial).
    Ahmed M; Anninga B; Goyal S; Young P; Pankhurst QA; Douek M;
    Br J Surg; 2015 May; 102(6):646-52. PubMed ID: 25868072
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Review of Novel Sentinel Lymph Node Biopsy Techniques in Breast Cancer Patients Treated With Neoadjuvant Chemotherapy.
    Ersoy YE; Kadioglu H
    Clin Breast Cancer; 2018 Aug; 18(4):e555-e559. PubMed ID: 29429940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sentinel lymph node biopsy in patients with breast cancer using superparamagnetic iron oxide and a magnetometer.
    Shiozawa M; Lefor AT; Hozumi Y; Kurihara K; Sata N; Yasuda Y; Kusakabe M
    Breast Cancer; 2013 Jul; 20(3):223-9. PubMed ID: 22240965
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Moving a neodymium magnet promotes the migration of a magnetic tracer and increases the monitoring counts on the skin surface of sentinel lymph nodes in breast cancer.
    Makita M; Manabe E; Kurita T; Takei H; Nakamura S; Kuwahata A; Sekino M; Kusakabe M; Ohashi Y
    BMC Med Imaging; 2020 May; 20(1):58. PubMed ID: 32460834
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo identification of sentinel lymph nodes using MRI and size-controlled and monodispersed magnetite nanoparticles.
    Iida S; Imai K; Matsuda S; Itano O; Hatakeyama M; Sakamoto S; Kokuryo D; Okabayashi K; Endo T; Ishii Y; Hasegawa H; Aoki I; Handa H; Kitagawa Y
    J Magn Reson Imaging; 2013 Dec; 38(6):1346-55. PubMed ID: 23554026
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized study comparing different doses of superparamagnetic iron oxide tracer for sentinel lymph node biopsy in breast cancer: The SUNRISE study.
    Rubio IT; Rodriguez-Revuelto R; Espinosa-Bravo M; Siso C; Rivero J; Esgueva A
    Eur J Surg Oncol; 2020 Dec; 46(12):2195-2201. PubMed ID: 32631710
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ASO Author Reflections: Pre-Operative Injection of Superparamagnetic Iron Oxide as the Only Localizing Tracer in Sentinel Lymph Node Biopsy in Early Breast Cancer.
    Man V; Suen D; Kwong A
    Ann Surg Oncol; 2023 Jun; 30(6):3245-3246. PubMed ID: 36897415
    [No Abstract]   [Full Text] [Related]  

  • 35. [Selective biopsy of the sentinel lymph node in patients with breast cancer and previous excisional biopsy: is there a change in the reliability of the technique according to time from surgery?].
    Sabaté-Llobera A; Notta PC; Benítez-Segura A; López-Ojeda A; Pernas-Simon S; Boya-Román MP; Bajén MT
    Rev Esp Med Nucl Imagen Mol; 2015; 34(1):9-12. PubMed ID: 25455507
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simplifying Logistics and Avoiding the Unnecessary in Patients With Breast Cancer Undergoing Sentinel Node Biopsy. A Prospective Feasibility Trial of the Preoperative Injection of Super Paramagnetic Iron Oxide Nanoparticles.
    Karakatsanis A; Olofsson H; Stålberg P; Bergkvist L; Abdsaleh S; Wärnberg F
    Scand J Surg; 2018 Jun; 107(2):130-137. PubMed ID: 29132268
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The value of contrast-enhanced ultrasound in determining the location of sentinel lymph nodes in breast cancer.
    Luo J; Feng L; Zhou Q; Chen Q; Liu J; Wu C; Luo J; Chen J; Wu H; Deng W
    Cancer Imaging; 2021 Mar; 21(1):28. PubMed ID: 33712074
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prospective Feasibility Trial of Sentinel Lymph Node Biopsy in the Setting of Inflammatory Breast Cancer.
    DeSnyder SM; Mittendorf EA; Le-Petross C; Krishnamurthy S; Whitman GJ; Ueno NT; Woodward WA; Kuerer HM; Akay CL; Babiera GV; Yang W; Lucci A
    Clin Breast Cancer; 2018 Feb; 18(1):e73-e77. PubMed ID: 28755879
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Axillary Staging After Neoadjuvant Chemotherapy for Breast Cancer: A Pilot Study Combining Sentinel Lymph Node Biopsy with Radioactive Seed Localization of Pre-treatment Positive Axillary Lymph Nodes.
    Diego EJ; McAuliffe PF; Soran A; McGuire KP; Johnson RR; Bonaventura M; Ahrendt GM
    Ann Surg Oncol; 2016 May; 23(5):1549-53. PubMed ID: 26727919
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A handheld SPIO-based sentinel lymph node mapping device using differential magnetometry.
    Waanders S; Visscher M; Wildeboer RR; Oderkerk TO; Krooshoop HJ; Ten Haken B
    Phys Med Biol; 2016 Nov; 61(22):8120-8134. PubMed ID: 27782005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.